Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion type Assertion NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_head.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion description "[Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion evidence source_evidence_literature NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion SIO_000772 24258714 NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion wasDerivedFrom befree-2016 NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion wasGeneratedBy ECO_0000203 NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.